BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12889219)

  • 1. Assessment of kidney involvement.
    Steen VD; Mayes MD; Merkel PA
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S29-31. PubMed ID: 12889219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of early onset normotensive scleroderma renal crisis in a patient with diffuse cutaneous systemic sclerosis.
    Bashandy HG; Javillo JS; Gambert SR
    South Med J; 2006 Aug; 99(8):870-2. PubMed ID: 16929883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma renal crisis and renal involvement in systemic sclerosis.
    Woodworth TG; Suliman YA; Li W; Furst DE; Clements P
    Nat Rev Nephrol; 2016 Nov; 12(11):678-691. PubMed ID: 27641135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
    Ng K; Gow P
    N Z Med J; 2007 May; 120(1254):U2537. PubMed ID: 17515941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of vascular involvement.
    Kahaleh B; Meyer O; Scorza R
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S9-14. PubMed ID: 12889215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney involvement in systemic sclerosis.
    Steen VD
    Presse Med; 2014 Oct; 43(10 Pt 2):e305-14. PubMed ID: 25174767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis in the absence of skin disease.
    Bhavsar SV; Carmona R
    J Clin Rheumatol; 2014 Oct; 20(7):379-82. PubMed ID: 25275766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of gastrointestinal involvement.
    Clements PJ; Becvar R; Drosos AA; Ghattas L; Gabrielli A
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S15-8. PubMed ID: 12889216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and outcome of Thai patients with scleroderma renal crisis: a disease duration-matched case control study.
    Wangkaew S; Lertthanaphok S; Puntana S; Noppakun K
    Int J Rheum Dis; 2017 Oct; 20(10):1562-1571. PubMed ID: 28752678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroderma renal crises: case report and review of literature.
    Sabir O; Younas H; Tanvir I; Tarif N
    J Pak Med Assoc; 2013 Jul; 63(7):916-8. PubMed ID: 23901721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors of Renal Involvement in Systemic Sclerosis.
    Rosato E; Gigante A; Barbano B; Gasperini ML; Cianci R; Muscaritoli M
    Kidney Blood Press Res; 2018; 43(3):682-689. PubMed ID: 29763902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleroderma renal crisis.
    Steen VD
    Rheum Dis Clin North Am; 1996 Nov; 22(4):861-78. PubMed ID: 8923600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma renal crisis, still a life-threatening complication.
    Teixeira L; Mahr A; Berezné A; Noël LH; Guillevin L; Mouthon L
    Ann N Y Acad Sci; 2007 Jun; 1108():249-58. PubMed ID: 17893990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal and extra-renal involvement in sclerodermia].
    Visconti L; Atteritano M; Buemi M; Santoro D
    G Ital Nefrol; 2014; 31(5):. PubMed ID: 25315720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progressive systemic scleroderma--prognosis determining involvement of internal organ systems].
    Mittag M; Haustein UF
    Hautarzt; 1998 Jul; 49(7):545-51. PubMed ID: 9715381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc.
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S49-56. PubMed ID: 12889224
    [No Abstract]   [Full Text] [Related]  

  • 19. Conclusion and identification of the core set of variables to be used in clinical investigations.
    Valentini G; Medsger TA; Silman AJ; Bombardieri S
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S47-8. PubMed ID: 12889223
    [No Abstract]   [Full Text] [Related]  

  • 20. Scleroderma renal crisis: new insights and developments.
    Rhew EY; Barr WG
    Curr Rheumatol Rep; 2004 Apr; 6(2):129-36. PubMed ID: 15016343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.